1. Izadi K, Ganchi P: Chronic wounds. Clin Plast Surg 32:209-222, 2005
2. Ramasastry SS: Acute wounds. Clin Plast Surg 32:195-208, 2005
3. Falanga V: Wound healing and its impairment in the diabetic foot. Lancet 366:1736-1743, 2005
4. Grose R, Werner S: Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 28:147-166, 2004
5. Martin P: Wound healing–aiming for perfect skin regeneration. Science 276:75-81, 1997
6. Alexopoulou AN, Multhaupt HA, Couchman JR: Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39:505-528, 2007
7. Higazi AA et al: Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis. Clin Exp Immunol 152:163-173, 2008
8. Falanga V et al: Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen 12:320-326, 2004
9. Havran WL, Jameson JM. Epidermal T cells and wound healing. J Immunol 184:5423-5428, 2010
10. Clark RA et al: Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 79:264-269, 1982
11. Xue M, Le NT, Jackson CJ: Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets 10:143-155, 2006
12. Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-870, 2003
13. Iida N, Grotendorst GR: Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Mol Cell Biol 10:5596-5599, 1990
14. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med 341:738-746, 1999
15. Weiss E et al: Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking. J Cell Physiol 174:58-65, 1998
16. Pardes JB et al: Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol 162:9-14, 1995
17. Martin P, Leibovich SJ: Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599-607, 2005
18. Doherty DE et al: Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium. J Immunol 138:1762-1771, 1987
19. Baum CL, Arpey CJ: Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31:674-686; discussion 86, 2005
20. Pull SL et al: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102:99-104, 2005
21. Newman SL, Henson JE, Henson PM: Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 156:430-442, 1982
22. Leibovich SJ, Ross R: The role of the macrophage in wound repair. A study with
hydrocortisone and antimacrophage serum.
Am J Pathol 78:71-100, 1975
23. Hopkinson-Woolley J et al: Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci 107(Pt 5):1159-1167, 1994
24. Zymek P et al: Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res 74:313-322, 2007
25. Luster AD et al: Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians 110:183-196, 1998
26. Heber-Katz E, Gourevitch D: The relationship between inflammation and regeneration in the MRL mouse: potential relevance for putative human regenerative (scarless wound healing) capacities? Ann N Y Acad Sci 1172:110-114, 2009
27. Martin P, Feng Y: Inflammation: wound healing in zebrafish. Nature 459:921-923, 2009
28. Panuncialman J, Falanga V: The science of wound bed preparation. Surg Clin North Am 89:611-626, 2009
29. Becchetti A, Arcangeli A: Integrins and ion channels in cell migration: implications for neuronal development, wound healing and metastatic spread. Adv Exp Med Biol 674:107-123, 2010
30. Wen T et al: Integrin alpha3 subunit regulates events linked to epithelial repair, including keratinocyte migration and protein expression. Wound Repair Regen 18:325-334, 2010
31. Santoro MM, Gaudino G: Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 304:274-286, 2005
32. Packer L, Fuehr K: Low
oxygen concentration extends the lifespan of cultured human diploid cells.
Nature 267:423-425, 1977
33. Falanga V, Kirsner RS: Low
oxygen stimulates proliferation of fibroblasts seeded as single cells.
J Cell Physiol 154:506-510, 1993
34. Knighton DR et al:
Oxygen tension regulates the expression of angiogenesis factor by macrophages.
Science 221:1283-1285, 1983
35. Falanga V et al: Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol 97:634-637, 1991
36. Kourembanas S et al: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88:1054-1057, 1991
37. Kourembanas S, Hannan RL, Faller DV:
Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells.
J Clin Invest 86:670-674, 1990
38. Shweiki D et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
39. Hopf HW et al: Hyperoxia and angiogenesis. Wound Repair Regen 13:558-564, 2005
40. Iyer V, Pumiglia K, DiPersio CM: Alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. J Cell Sci 118:1185-1195, 2005
41. Choma DP et al: Integrin alpha3beta1-Dependent Activation of FAK/Src Regulates Rac1-Mediated Keratinocyte Polarization on Laminin-5. J Invest Dermatol 127(1):31-40 2006
42. Choma DP, Pumiglia K, DiPersio CM: Integrin alpha3beta1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J Cell Sci 117:3947-3959, 2004
43. Yan C et al: Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am J Pathol 176:2247-2258, 2010
44. Nahm WK et al: Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol 200:309-317, 2004
45. Martin P, Parkhurst SM: Parallels between tissue repair and embryo morphogenesis. Development 131:3021-3034, 2004
46. Hattori N et al: MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol 175:533-546, 2009
47. Schultz GS, Wysocki A: Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17:153-162, 2009
48. Toy LW: Matrix metalloproteinases: their function in tissue repair. J Wound Care 14:20-22, 2005
49. Philp D et al: Thymosin beta(4) promotes matrix metalloproteinase expression during wound repair. J Cell Physiol 208:195-200, 2006
50. Shephard P et al: Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol 164:2055-2066, 2004
51. Ito M et al: Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 11:1351-1354, 2005
52. Ito M et al: Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447:316-320, 2007
53. Buchanan EP, Longaker MT, Lorenz HP: Fetal skin wound healing. Adv Clin Chem 48:137-161, 2009
54. Karvinen S et al: Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J Biol Chem 278:49495-49504, 2003
55. Yevdokimova NY, Podpryatov SE: Hyaluronic acid production and CD44 expression in cultured dermal fibroblasts of patients with non-insulin-dependent diabetes mellitus with and without chronic ulcers on the lower extremity. Wound Repair Regen 13:181-188, 2005
56. Lark MW, Laterra J, Culp LA: Close and focal contact adhesions of fibroblasts to a fibronectin-containing matrix. Fed Proc 44:394-403, 1985
57. Lawrence WT: Physiology of the acute wound. Clin Plast Surg 25:321-340, 1998
58. Zhang S et al: The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem 273:11342-11348, 1998
59. Canty EG, Kadler KE: Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118:1341-1353, 2005
60. Hinman CD, Maibach H: Effect of air exposure and occlusion on experimental human skin wounds. Nature 200:377-378, 1963
61. Winter GD: Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 193:293-294, 1962
62. Goossens A, Cleenewerck MB: New wound dressings: classification, tolerance. Eur J Dermatol 20:24-26, 2010
63. Ovington LG: Advances in wound dressings. Clin Dermatol 25:33-38, 2007
64. Hunt TK et al: Wound healing. Science 284:1775, 1999
65. Ovington LG: Wound care products: how to choose. Adv Skin Wound Care 14:259-264; quiz 65-66, 2001
66. Ovington LG: The evolution of wound management: ancient origins and advances of the past 20 years. Home Healthc Nurse 20:652-656, 2002
67. Hutchinson JJ: Infection under occlusion. Ostomy Wound Manage 40:28-30, 32-33, 1994
68. Hutchinson JJ, Lawrence JC: Wound infection under occlusive dressings. J Hosp Infect 17:83-94, 1991
69. Smith DJ Jr et al: Microbiology and healing of the occluded skin-graft donor site. Plast Reconstr Surg 91:1094-1097, 1993
70. Harding KG, Jones V, Price P: Topical treatment: which dressing to choose. Diabetes Metab Res Rev 16(Suppl. 1):S47-S50, 2000
71. Weiss DS, Eaglstein WH, Falanga V: Exogenous electric current can reduce the formation of hypertrophic scars. J Dermatol Surg Oncol 15:1272-1275, 1989
72. Farboud B et al: DC electric fields induce rapid directional migration in cultured human corneal epithelial cells. Exp Eye Res 70:667-673, 2000
73. Sillman AL et al: Human dermal fibroblasts do not exhibit directional migration on
collagen I in direct-current electric fields of physiological strength.
Exp Dermatol 12:396-402, 2003
74. Katz MH et al: Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 25:1054-1058, 1991
75. Seah CC et al: Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway. J Invest Dermatol 124:466-474, 2005
76. Schuster R, Moradzadeh A, Waxman K: The use of vacuum-assisted closure therapy for the treatment of a large infected facial wound. Am Surg 72:129-131, 2006
77. Kumar V, Fausto N, Abbas AK: Tissue renewal and repair: regeneration, healing, and fibrosis. In: Robbins and Cotran Pathologic Basis of Disease, 7th edition, edited by V Kumar, N Fausto, AK Abbas. Philadelphia, Elsevier, 2005, pp. 87-118
78. Smahel J: Free skin transplantation on a prepared bed. Br J Plast Surg 24:129-132, 1971
79. Gingrass P, Grabb WC, Gingrass RP: Skin graft survival on avascular defects. Plast Reconstr Surg 55:65-70, 1975
80. Johnson TM, Ratner D, Nelson BR: Soft tissue reconstruction with skin grafting. J Am Acad Dermatol 27:151-165, 1992
81. Christensen DR, Arpey CJ, Whitaker DC: Skin Grafting. In: Surgery of the Skin, edited by JK Robinson, CW Hanke, RD Sengelmann, DM Siegel. New York, Elsevier Mosby, 2005, pp. 365-379
82. Clemmesen T, Ronhovde DA: Restoration of the blood-supply to human skin autografts. Scand J Plast Reconstr Surg 2:44-46, 1968
83. Mir y Mir L: Biology of the skin graft; new aspects to consider in its revascularization. Plast Reconstr Surg 8:378-389, 1951
84. Converse JM, Uhlschmid GK, Ballantyne DL Jr: “Plasmatic circulation” in skin grafts. The phase of serum imbibition. Plast Reconstr Surg 43:495-499, 1969
85. Clemmesen T: The early circulation in split skin grafts. Acta Chir Scand 124:11-18, 1962
86. Smahel J: Biology of the stage of plasmatic imbibition. Br J Plast Surg 24:140-143, 1971
87. Smahel J: The healing of skin grafts. Clin Plast Surg 4:409-424, 1977
88. Maeda M et al: The role of serum imbibition for skin grafts. Plast Reconstr Surg 104:2100-2107, 1999
89. Psillakis JM: Lymphatic vascularization of skin grafts. Plast Reconstr Surg 43:287-291, 1969
90. Henry L et al: A histological study of the human skin graft. Am J Pathol 39:317-332, 1961
91. Smahel J, Clodius L: The blood vessel system of free human skin grafts. Plast Reconstr Surg 47:61-66, 1971
92. Lambert PB: Vascularization of skin grafts. Nature 232:279-280, 1971
93. Black AF et al: In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. Faseb J 12:1331-1340, 1998
94. Tremblay PL et al: Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 5:1002-1010, 2005
95. Plenat F et al: Host-donor interactions in healing of human split-thickness skin grafts onto nude mice: in situ hybridization, immunohistochemical, and histochemical studies. Transplantation 53:1002-1010, 1992
96. Capla JM et al: Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plast Reconstr Surg 117:836-844, 2006
97. Waris T: Innervation of the skin, skin transplants, flaps and scars. An experimental, histochemical study in the rat. Acta Chir Scand Suppl 485:1-48, 1978
98. Fitzgerald MJ, Martin F, Paletta FX: Innervation of skin grafts. Surg Gynecol Obstet 124:808-812, 1967
99. Waris T, Rechardt L, Kyosola K: Reinnervation of human skin grafts: a histochemical study. Plast Reconstr Surg 72:439-447, 1983
100. Tuncali D et al: Effect of full-thickness skin graft initial dimension on secondary wound contraction: experimental study in rats. Dermatol Surg 31:542-545, 2005
101. Tsukada S: The melanocytes and melanin in human skin autografts. Plast Reconstr Surg 53:200-207, 1974
102. Kirsner RS, Falanga V, Eaglstein WH: The biology of skin grafts. Arch Dermatol 129:481-483, 1993
103. Kirsner RS et al: Skin Grafts as pharmacological agents: pre-wounding of the donor site. Br J Dermatol 135:292-296, 1996
104. Yamaguchi Y et al: Involvement of keratinocyte activation phase in cutaneous graft healing: comparison of full-thickness and split-thickness skin grafts. Dermatol Surg 26:463-468, 2000
105. Baur PS Jr, Parks DH, Hudson JD: Epithelial mediated wound contraction in experimental wounds–the purse-string effect. J Trauma 24:713-720, 1984
106. Harrison CA, MacNeil S: The mechanism of skin graft contraction: an update on current research and potential future therapies. Burns 34:153-163, 2008
107. Harrison CA et al: Use of an in vitro model of tissue-engineered skin to investigate the mechanism of skin graft contraction. Tissue Eng 12:3119-3133, 2006
108. Beanes SR et al: Skin repair and scar formation: the central role of TGF-beta. Expert Rev Mol Med 5:1-22, 2003
109. LoGerfo FW, Coffman JD: Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 311:1615-1619, 1984
110. Stacey M et al: Compression therapy in the treatment of venous leg ulcers. Nurs Times 98:39-43, 2002
111. Browse NL, Burnand KG: The cause of venous ulceration. Lancet 2:243-245, 1982
112. Falanga V et al: Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol 123:620-623, 1987
113. Coleridge Smith PD: The microcirculation in venous hypertension. Vasc Med 2:203-213, 1997
114. Higley HR et al: Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol 132:79-85, 1995
115. Falanga V, Eaglstein WH: The “trap” hypothesis of venous ulceration. Lancet 341:1006-1008, 1993
116. Grinnell F, Ho CH, Wysocki A: Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-416, 1992
117. Ladwig GP et al: Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 10:26-37, 2002
118. Greenberg AS et al: Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol 35:566-568, 1996
119. Mendez MV et al: Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 28:876-883, 1998
120. Hasan A et al: Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci 16:59-66, 1997
121. Kim BC et al: Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol 195:331-336, 2003
122. Agren MS et al: Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 112:463-469, 1999
123. Pastar I et al: Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med 16:92-101, 2010
124. Loots MA et al: Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 111:850-857, 1998
125. Saap L et al: Contact sensitivity in patients with leg ulcerations: a North American study. Arch Dermatol 140:1241-1246, 2004
126. Falanga V et al: Systemic treatment of venous leg ulcers with high doses of
pentoxifylline: efficacy in a randomized, placebo-controlled trial.
Wound Repair Regen 7:208-213, 1999
127. Helfman T, Falanga V: Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 33:254-258, 1995
128. Steed DL et al: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 183:61-64, 1996
129. Tawes RL et al: Optimal therapy for advanced chronic venous insufficiency. J Vasc Surg 37:545-551, 2003
130. Hamdan AD et al: Lack of association of diabetes with increased postoperative mortality and cardiac morbidity: results of 6565 major vascular operations. Arch Surg 137:417-421, 2002
131. Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117:143S-149S; discussion 50S-51S, 2006
132. Bello YM, Phillips TJ: Recent advances in wound healing. JAMA 283:716-718, 2000
133. Shen JT, Falanga V: Innovative therapies in wound healing. J Cutan Med Surg 7:217-224, 2003
134. Marston WA et al: The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26:1701-1705, 2003
135. Falanga V et al: Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 134:293-300, 1998
136. Falanga V, Sabolinski M: A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 7:201-207, 1999
137. Veves A et al: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24:290-295, 2001
138. Phillips TJ et al: The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol 138:1079-1081, 2002
139. Cha J, Falanga V: Stem cells in cutaneous wound healing. Clin Dermatol 25:73-78, 2007
140. Yu J et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920, 2007
141. Daley GQ: Stem cells: roadmap to the clinic. J Clin Invest 120:8-10, 2010
142. Fu X, Sun X: Can hematopoietic stem cells be an alternative source for skin regeneration? Ageing Res Rev 8:244-249, 2009
143. Falanga V et al: Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13:1299-1312, 2007
144. Templin C et al: Ex vivo expanded haematopoietic progenitor cells improve dermal wound healing by paracrine mechanisms. Exp Dermatol 18:445-453, 2009
145. Tallman P et al: Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol 133:1231-1234, 1997
146. Gelfand JM, Hoffstad O, Margolis DJ: Surrogate endpoints for the treatment of venous leg ulcers. J Invest Dermatol 119:1420-1425, 2002
147. Cardinal M et al: Early healing rates and wound area measurements are reliable predictors of later complete wound closure. Wound Repair Regen 16:19-22, 2008